참고문헌 (121)

1. 1 Aguado-Llera D Arilla-Ferreiro E Campos-Barros A Puebla-Jiménez L Barrios V Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of beta-amyloid-treated rats. J. Neurochem. (2005) 92 607 615 15659230 

2. 2 Ahmed M Davis J Aucoin D Sato T Ahuja S Aimoto S Elliott J. I Van Nostrand W. E Smith S. O Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat.Struct. Mol. Biol. (2010) 17 561 567 20383142 

3. 3 Akiyama H Kondo H Ikeda K Kato M McGeer P. L Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein(Abeta) deposition. Brain Res. (2001) 902 277 281 11384622 

4. 4 Ayoub S Melzig M. F Induction of neutral endopeptidase(NEP) activity of SK-N-SH cells by natural compounds from green tea. J. Pharm. Pharmacol. (2006) 58 495 501 16597367 

   상세보기

5. 5 Baig S Kehoe P. G Love S MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease. Neuropathol. Appl. Neurobiol. (2008) 34 205 215 17971072 

6. 6 Bateman R. J Munsell L. Y Morris J. C Swarm R Yarasheski K. E Holtzman D. M Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat. Med. (2006) 12 856 861 16799555 

7. 7 Bell R. D Sagare A.P Friedman A. E Bedi G. S Holtzman D.M Deane R Zlokovic B. V Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. (2007) 27 909 918 17077814 

   상세보기

8. 8 Belyaev N. D Nalivaeva N. N Makova N. Z Turner A. J Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. (2009) 10 94 100 19057576 

   상세보기

9. 9 Bruno M. A Mufson E. J Wuu J Cuello A. C Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J. Neuropathol. Exp. Neurol. (2009) 68 1309 1318 19915485 

   상세보기

10. 10 Bu G Cam J Zerbinatti C LRP in amyloid-beta production and metabolism. Ann. N. Y. Acad. Sci. (2006) 1086 35 53 17185504 

    상세보기

11. 11 Burgos-Ramos E Martos-Moreno G. A López M. G Herranz R Aguado-Llera D Egea J Frechilla D Cenarruzabeitia E León R Arilla-Ferreiro E Argente J Barrios V The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation. J. Neurochem. (2009a) 109 360 370 19220704 

12. 12 Burgos-Ramos E Puebla-Jiménez L Arilla-Ferreiro E Minocycline prevents Abeta(25-35)-induced reduction of soma-tostatin and neprilysin content in rat temporal cortex. Life Sci. (2009b) 84 205 210 19101571 

13. 13 Carare R. O Bernardes-Silva M Newman T. A Page A. M Nicoll J. A Perry V. H Weller R. O Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: signifi cance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. (2008) 34 131 144 18208483 

    상세보기

14. 14 Castellani R. J Smith M. A Compounding artefacts with uncertainty and an amyloid cascade hypothesis that is 'too big to fail'. J. Pathol. (2011) 224 147 152 21557219 

    상세보기

15. 15 Choi D. S Wang D Yu G. Q Zhu G Kharazia V. N Paredes J.P Chang W. S Deitchman J. K Mucke L Messing R. O PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc. Natl. Acad. Sci. USA (2006) 103 8215 8220 16698938 

    상세보기

16. 16 Danielyan L Schäfer R Schulz A Ladewig T Lourhmati A Buadze M Schmitt A. L Verleysdonk S Kabisch D Koeppen K Siegel G Proksch B Kluba T Eckert A Köhle C Schöneberg T Northoff H Schwab M Gleiter C. H Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Cell Death Differ. (2009) 16 1599 1614 19609278 

    상세보기

17. 17 Deane R Bell R. D Sagare A Zlokovic B. V Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets (2009) 8 16 30 19275634 

    상세보기

18. 18 Deane R Wu Z Sagare A Davis J Du Yan S Hamm K Xu F Parisi M LaRue B Hu H. W Spijkers P Guo H Song X Lenting P. J Van Nostrand W. E Zlokovic B. V LRP/amyloid beta-peptide interaction mediates differential brain effl ux of Abeta isoforms. Neuron (2004) 43 333 344 15294142 

19. 19 Deb S Gottschall P. E Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. (1996) 66 1641 1647 8627321 

20. 20 Deb S Zhang J. W Gottschall P. E Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide. J. Neurosci. Res. (1999) 55 44 53 9890433 

21. 21 Dong Y. F Kataoka K Tokutomi Y Nako H Nakamura T Toyama K Sueta D Koibuchi N Yamamoto E Ogawa H Kim-Mitsuyama S Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J. (2011) 25 2911 2920 21593435 

22. 22 Eckman E. A Adams S. K Troendle F. J Stodola B. A Kahn M.A Fauq A. H Xiao H. D Bernstein K. E Eckman C. B Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J. Biol. Chem. (2006) 281 30471 30478 16912050 

23. 23 Eckman E. A Watson M Marlow L Sambamurti K Eckman C. B Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem. (2003) 278 2081 2084 12464614 

24. 24 Eisele Y. S Baumann M Klebl B Nordhammer C Jucker M Kilger E Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. Mol. Biol. Cell. (2007) 18 3591 3600 17626163 

25. 25 El-Amouri S. S Zhu H Yu J Marr R Verma I. M Kindy M.S Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am. J. Pathol. (2008) 172 1342 1354 18403590 

    상세보기

26. 26 Espuny-Camacho I Dominguez D Merchiers P Van Rompaey L Selkoe D De Strooper B Peroxisome proliferator-activated receptor gamma enhances the activity of an insulin degrading enzyme-like metalloprotease for amyloid-beta clearance. J. Alzheimers Dis. (2010) 20 1119 1132 20413872 

27. 27 Fabbro S Seeds N. W Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J. Neurochem. (2009) 109 303 315 19222708 

    상세보기

28. 28 Farris W Mansourian S Chang Y Lindsley L Eckman E. A Frosch M. P Eckman C. B Tanzi R. E Selkoe D. J Guenette S Insulin-degrading enzyme regulates the levels of insulin amyloid beta-protein and the beta-amyloid precursor protein, intracellular domain in vivo. Proc. Natl. Acad. Sci. USA (2003) 100 4162 4167 12634421 

    상세보기

29. 29 Farris W Schütz S. G Cirrito J. R Shankar G. M Sun X George A Leissring M. A Walsh D. M Qiu W. Q Holtzman D. M Selkoe D. J Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am. J. Pathol. (2007) 171 241 251 17591969 

    상세보기

30. 30 Floden A. M Combs C. K Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J. Alzheimers Dis. (2011) 25 279 293 21403390 

31. 31 Frautschy S. A Yang F Irrizarry M Hyman B Saido T. C Hsiao K Cole G. M Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. (1998) 152 307 317 9422548 

    상세보기

32. 32 Hafez D Huang J. Y Huynh A. M Valtierra S Rockenstein E Bruno A. M Lu B DesGroseillers L Masliah E Marr R. A Neprilysin-2 is an important β-amyloid degrading enzyme. Am. J. Pathol. (2011) 178 306 312 21224067 

    상세보기

33. 33 Hama E Shirotani K Masumoto H Sekine-Aizawa Y Aizawa H Saido T. C Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J. Biochem. (2001) 130 721 726 11726269 

34. 34 Hardy J. A Higgins G. A Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 256 184 185 1566067 

    상세보기

35. 35 Hardy J Selkoe D. J The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 297 353 356 12130773 

    상세보기

36. 36 Hellström-Lindahl E Ravid R Nordberg A Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol. Aging (2008) 29 210 221 17098332 

37. 37 Hildebrandt H Haldenwanger A Eling P False recognition correlates with amyloid-beta (1-42) but not with total tau in cerebrospinal fluid of patients with dementia and mild cognitive impairment. J. Alzheimers Dis. (2009) 16 157 165 19158431 

38. 38 Hong H Baik T Song K Nam I Chung M Jo S In silico study of interaction between neurotransmitters and β-amyloid peptide (Aβ): a novel working hypothesis of Aβ-mediated pathogenesis of Alzheimer’s disease. (Submitted) 

39. 39 Huang S. M Mouri A Kokubo H Nakajima R Suemoto T Higuchi M Staufenbiel M Noda Y Yamaguchi H Nabeshima T Saido T. C Iwata N Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. (2006) 281 17941 17951 16636059 

40. 40 Iwata N Mizukami H Shirotani K Takaki Y Muramatsu S Lu B Gerard N. P Gerard C Ozawa K Saido T. C Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J. Neurosci. (2004) 24 991 998 14749444 

41. 41 Iwata N Tsubuki S Takaki Y Shirotani K Lu B Gerard N. P Gerard C Hama E Lee H. J Saido T. C Metabolic regulation of brain Abeta by neprilysin. Science (2001) 292 1550 1552 11375493 

    상세보기

42. 42 Jacobsen J. S Comery T. A Martone R. L Elokdah H Crandall D. L Oganesian A Aschmies S Kirksey Y Gonzales C Xu J Zhou H Atchison K Wagner E Zaleska M. M Das I Arias R. L Bard J Riddell D Gardell S. J Abou-Gharbia M Robichaud A Magolda R Vlasuk G. P Bjornsson T Reinhart P. H Pangalos M. N Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc. Natl. Acad. Sci. USA (2008) 105 8754 8759 18559859 

    상세보기

43. 43 Jaeger L. B Dohgu S Hwang M. C Farr S. A Murphy M. P Fleegal-DeMotta M. A Lynch J. L Robinson S. M Niehoff M.L Johnson S. N Kumar V. B Banks W. A Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J. Alzheimers Dis. (2009) 17 553 570 19433890 

44. 44 Jarrett J. T Berger E. P Lansbury P. T. Jr The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 32 4693 4697 8490014 

45. 45 Jo S. A Ahn K Kim E Kim H. S Jo I Kim D. K Han C Park M. H Association of BACE1 gene polymorphism with Alzheimer's disease in Asian populations: meta-analysis including Korean samples. Dement. Geriatr. Cogn. Disord. (2008) 25 165 169 18182766 

    상세보기

46. 46 Jung S. S Zhang W Van Nostrand W. E Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J. Neurochem. (2003) 85 1208 1215 12753080 

47. 47 Kalinin S Richardson J. C Feinstein D. L A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease. Curr. Alzheimer. Res. (2009) 6 431 437 19874267 

48. 48 Kim J. Y Kim D. H Kim J. H Lee D Jeon H. B Kwon S. J Kim S. M Yoo Y. J Lee E. H Choi S. J Seo S. W Lee J. I Na D. L Yang Y. S Oh W Chang J. W Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques. Cell Death Differ. (2012) 19 680 691 22015609 

    상세보기

49. 49 Kim K. W Kim M. H Kim M. D Kim B. J Kim S. K Kim J. L Moon S. W Bae J. N Woo J. I Ryu S. H Yoon J.C Lee N. J Lee D. Y Lee D. W Lee S. B Lee J. J Lee JY Lee CU Chang S. M Jhoo J. H Cho M. J A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J. Alzheimers Dis. (2011a) 23 281 291 21178286 

50. 50 Kim M. J Chae S. S Koh Y. H Lee S. K Jo S. A Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain. FASEB J. (2010) 24 4491 4502 20624932 

    상세보기

51. 51 Kim T Hinton D. J Choi D. S Protein kinase C-regulated aβ production and clearance. Int. J. Alzheimers Dis. (2011b) 857368 21274428 

52. 52 Kiss A Kowalski J Melzig M. F Effect of Epilobium angustifolium L. extracts and polyphenols on cell proliferation and neutral endopeptidase activity in selected cell lines. Pharmazie (2006) 61 66 69 16454210 

    상세보기

53. 53 Krauze M. T Saito R Noble C Bringas J Forsayeth J McKnight T. R Park J Bankiewicz K. S Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp. Neurol. (2005) 196 104 111 16109410 

    상세보기

54. 54 Laurén J Gimbel D. A Nygaard H. B Gilbert J. W Strittmatter S. M Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 457 1128 1132 19242475 

55. 55 Leal M. C Dorfman V. B Gamba A. F Frangione B Wisniewski T Castaño E. M Sigurdsson E. M Morelli L Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology. J. Neuropathol. Exp. Neurol. (2006) 65 976 987 17021402 

    상세보기

56. 56 Leal M. C Surace E. I Holgado M. P Ferrari C. C Tarelli R Pitossi F Wisniewski T Castaño E. M Morelli L Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolism. Biochim. Biophys. Acta (2012) 1823 227 235 22036964 

57. 57 Lee J. M Yin K. J Hsin I Chen S Fryer J. D Holtzman D. M Hsu C. Y Xu J Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann. Neurol. (2003) 54 379 382 12953271 

    상세보기

58. 58 Leissring M. A Farris W Chang A. Y Walsh D. M Wu X Sun X Frosch M. P Selkoe D. J Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formationsecondary pathology, and premature death. Neuron (2003) 40 1087 1093 14687544 

59. 59 Liang K Yang L Yin C Xiao Z Zhang J Liu Y Huang J Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J. Biol. Chem. (2010) 285 935 942 19897485 

60. 60 Liu Y Studzinski C Beckett T Murphy M. P Klein R. L Hersh L. B Circulating neprilysin clears brain amyloid. Mol. Cell Neurosci. (2010) 45 101 107 20558294 

    상세보기

61. 61 Love S Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry (2004) 75 1 4 14707293 

    상세보기

62. 62 Madani R Poirier R Wolfer D. P Welzl H Groscurth P Lipp H. P Lu B El Mouedden M Mercken M Nitsch R. M Mohajeri M. H Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral defi cit in vivo. J. Neurosci. Res. (2006) 84 1871 1878 16998901 

    상세보기

63. 63 Marr R. A Rockenstein E Mukherjee A Kindy M. S Hersh L. B Gage F. H Verma I. M Masliah E Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. (2003) 23 1992 1996 12657655 

    상세보기

64. 64 Meilandt W. J Cisse M Ho K Wu T Esposito L. A Scearce-Levie K Cheng I. H. Yu G. Q Mucke L Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J. Neurosci. (2009) 29 1977 1986 19228952 

    상세보기

65. 65 Melino G Draoui M Bernardini S Bellincampi L Reichert U Cohen P Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines. Cell Growth Differ. (1996) 7 787 796 8780892 

66. 66 Melzig M. F Escher F Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol. Pharmazie (2002) 57 556 558 12227197 

    상세보기

67. 67 Melzig M. F Janka M Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Phytomedicine (2003) 10 494 498 13678233 

    상세보기

68. 68 Miller B. C Eckman E. A Sambamurti K Dobbs N Chow K. M Eckman C. B Hersh L. B Thiele D. L Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc. Natl. Acad. Sci. USA (2003) 100 6221 6226 12732730 

    상세보기

69. 69 Miners J. S Ashby E Van Helmond Z Chalmers K. A Palmer L. E Love S Kehoe P. G Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. (2008a) 34 181 193 17973905 

    상세보기

70. 70 Miners J. S Baig S Tayler H Kehoe P. G Love S Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J. Neuropathol. Exp. Neurol. (2009) 68 902 914 19606063 

    상세보기

71. 71 Miners J. S Kehoe P. G Love S Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates. J. Neurosci. Methods (2008b) 169 177 181 18221786 

    상세보기

72. 72 Miners J. S Morris S Love S Kehoe P. G Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities. J. Alzheimers Dis. (2011) 23 101 108 20930275 

73. 73 Miners J. S van Helmond Z Chalmers K Wilcock G Love S Kehoe P. G Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. (2006) 65 1012 1021 17021406 

    상세보기

74. 74 Miners J. S van Helmond Z Kehoe P. G Love S Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol. (2010a) 20 794 802 20175776 

75. 75 Miners J. S van Helmond Z Raiker M Love S Kehoe P. G ACE variants and association with brain Aβ levels in Alzheimer's disease. Am. J. Transl. Res. (2010b) 3 73 80 21139807 

76. 76 Miners J. S Verbeek M. M Rikkert M. O Kehoe P. G Love S Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J. Neurosci. Methods (2008c) 167 229 236 17904641 

    상세보기

77. 77 Mohajeri M. H Wollmer M. A Nitsch R. M Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J. Biol. Chem. (2002) 277 35460 35465 12105192 

    상세보기

78. 78 Monro O. R Mackic J. B Yamada S Segal M. B Ghiso J Maurer C Calero M Frangione B Zlokovic B. V Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging (2002) 23 405 412 11959403 

79. 79 Mouri A Zou L. B Iwata N Saido T. C Wang D Wang M. W Noda Y Nabeshima T Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behav. Brain Res. (2006) 168 83 91 16360221 

80. 80 Mueller-Steiner S Zhou Y Arai H Roberson E. D Sun B Chen J Wang X Yu G Esposito L Mucke L Gan L Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron (2006) 51 703 714 16982417 

    상세보기

81. 81 Naert G Rivest S The role of microglial cell subsets in Alzheimer's disease. Curr. Alzheimer Res. (2011) 8 151 155 21418002 

82. 82 Nalivaeva N. N Beckett C Belyaev N. D Turner A. J Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. (2012) 120 Suppl 1 167 185 22122230 

83. 83 Narita M Holtzman D. M Schwartz A. L Bu G Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. (1997) 69 1904 1911 9349534 

84. 84 Nielsen H. M Veerhuis R Holmqvist B Janciauskiene S Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia (2009) 57 978 988 19062178 

85. 85 Numata K Kaplan D. L Mechanisms of enzymatic degradation of amyloid Beta microfibrils generating nanofilaments and nanospheres related to cytotoxicity. Biochemistry (2010) 49 3254 3260 20196618 

86. 86 Palmer J. C Baig S Kehoe P. G Love S Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. Am. J. Pathol. (2009) 175 262 270 19541930 

87. 87 Palmer J. C Barker R Kehoe P. G Love S Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated byAmyloid-β. J. Alzheimers Dis. (2012) 29 853 861 22330820 

88. 88 Pardossi-Piquard R Petit A Kawarai T Sunyach C Alves da Costa C Vincent B Ring S D'Adamio L Shen J Müller U St George Hyslop P Checler F Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron (2005) 46 541 554 15944124 

89. 89 Pflanzner T Petsch B André-Dohmen B Müller-Schiffmann A Tschickardt S Weggen S Stitz L Korth C Pietrzik C. U Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. J. Cereb. Blood Flow Metab. (2012) 32 628 632 22293988 

    상세보기

90. 90 Pike C. J Walencewicz-Wasserman A. J Kosmoski J Cribbs D. H Glabe C. G Cotman C. W Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. (1995) 64 253 265 7798921 

91. 91 Poirier R Wolfer D. P Welzl H Tracy J Galsworthy M. J Nitsch R. M Mohajeri M. H Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit. Neurobiol. Dis. (2006) 24 475 483 17008108 

92. 92 Pulukuri S. M Estes N Patel J Rao J. S Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res. (2007) 67 930 939 17283123 

    상세보기

93. 93 Rogers J Strohmeyer R Kovelowski C. J Li R Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia (2002) 40 260 269 12379913 

94. 94 Russo R Borghi R Markesbery W Tabaton M Piccini A Neprylisin decreases uniformly in Alzheimer's disease and in normal aging. FEBS Lett. (2005) 579 6027 6030 16226260 

    상세보기

95. 95 Rylski M Amborska R Zybura K Michaluk P Bielinska B Konopacki F. A Wilczynski G. M Kaczmarek L JunB is a repressor of MMP-9 transcription in depolarized rat brain neurons. Mol. Cell Neurosci. (2009) 40 98 110 18976709 

    상세보기

96. 96 Rylski M Amborska R Zybura K Mioduszewska B Michaluk P Jaworski J Kaczmarek L Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons. J. Biol. Chem. (2008) 283 35140 35153 18940814 

    상세보기

97. 97 Sagare A. P Deane R Zetterberg H Wallin A Blennow K Zlokovic B. V Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease. J. Alzheimers Dis. (2011) 24 25 34 21157031 

98. 98 Sagare A Deane R Bell R. D Johnson B Hamm K Pendu R Marky A Lenting P. J Wu Z Zarcone T Goate A Mayo K Perlmutter D Coma M Zhong Z Zlokovic B. V Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. (2007) 13 1029 1031 17694066 

99. 99 Saito T Iwata N Tsubuki S Takaki Y Takano J Huang S. M Suemoto T Higuchi M Saido T. C Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med. (2005) 11 434 439 15778722 

100. 100 Savaskan E Hock C Olivieri G Bruttel S Rosenberg C Hulette C Müller-Spahn F Cortical alterations of angiotensin converting enzyme angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol. Aging (2001) 22 541 546 11445253 

     상세보기

101. 101 Sehgal N Gupta A Valli R. K Joshi S. D Mills J. T Hamel E Khanna P Jain S. C Thakur S. S Ravindranath V Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA (2012) 109 3510 3515 22308347 

     상세보기

102. 102 Selkoe D. J Alzheimer's disease. In the beginning... Nature (1991) 35 432 433 1684220 

103. 103 Shibata M Yamada S Kumar S. R Calero M Bading J Frangione B Holtzman D. M Miller C. A Strickland D. K Ghiso J Zlokovic B. V Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. (2000) 106 1489 1499 11120756 

     상세보기

104. 104 Simard A. R Soulet D Gowing G Julien J. P Rivest S Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron (2006) 49 489 502 16476660 

     상세보기

105. 105 Spencer B Marr R. A Rockenstein E Crews L Adame A Potkar R Patrick C Gage F. H Verma I. M Masliah E Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci. (2008) 9 109 19014502 

     상세보기

106. 106 Tanzi R. E Bertram L Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell (2005) 120 545 555 15734686 

     상세보기

107. 107 Tucker H. M Kihiko M Caldwell J. N Wright S Kawarabayashi T Price D Walker D Scheff S McGillis J. P Rydel R. E Estus S The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. (2000) 20 3937 3946 10818128 

108. 108 Tucker H. M Simpson J Kihiko-Ehmann M Younkin L. H McGillis J. P Younkin S. G Degen J. L Estus S Plasmin defi ciency does not alter endogenous murine amyloid beta levels in mice. Neurosci. Lett. (2004) 368 285 289 15364412 

     상세보기

109. 109 Viswanathan A Greenberg S. M Cerebral amyloid angiopathy in the elderly. Ann. Neurol. (2011) 70 871 880 22190361 

     상세보기

110. 110 Wang H. Y Lee D. H Davis C. B Shank R. P Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J. Neurochem. (2000) 75 1155 1161 10936198 

111. 111 Wang R Wang S Malter J. S Wang D. S Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells. J. Alzheimers Dis. (2009a) 17 489 501 19363254 

112. 112 Wang R Wang S Malter J. S Wang D. S Effects of HNE-modifi cation induced by Abeta on neprilysin expression and activity in SH-SY5Y cells. J. Neurochem. (2009b) 108 1072 1082 19196432 

113. 113 Weller R. O Massey A Kuo Y. M Roher A. E Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann. N. Y. Acad. Sci. (2000) 903 110 117 10818495 

114. 114 Weller R. O Subash M Preston S. D Mazanti I Carare R. O Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. (2008) 18 253 266 18363936 

115. 115 Wyss-Coray T Infl ammation in Alzheimer disease: driving force bystander or benefi cial response? Nat. Med. (2006) 12 1005 1015 16960575 

     상세보기

116. 116 Wyss-Coray T Loike J. D Brionne T. C Lu E Anankov R Yan F Silverstein S. C Husemann J Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. (2003) 9 453 457 12612547 

117. 117 Xiao Z. M Sun L Liu Y. M Zhang J. J Huang J Estrogen regulation of the neprilysin gene through a hormone-responsive element. J. Mol. Neurosci. (2009) 39 22 26 19127446 

     상세보기

118. 118 Yan P Hu X Song H Yin K Bateman R. J Cirrito J. R Xiao Q Hsu F. F Turk J. W Xu J Hsu C. Y Holtzman D. M Lee J. M Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. (2006) 281 24566 24574 16787929 

119. 119 Yang L Xu S Liu C Su Z In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry. Anal. Bioanal. Chem. (2009) 395 1441 1451 19774367 

     상세보기

120. 120 Yuyama K Sun H Mitsutake S Igarashi Y Sphingolipid-modulated exosome secretion promotes the clearance of amyloid-β by microglia. J. Biol. Chem. (2012) [Epub ahead of print] 

121. 121 Zou L. B Mouri A Iwata N Saido T. C Wang D Wang M. W Mizoguchi H Noda Y Nabeshima T Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory. J. Pharmacol. Exp. Ther. (2006) 317 334 340 16382024 

     상세보기